Steward Partners Investment Advisory, LLC Novo Cure LTD Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 749 shares of NVCR stock, worth $13,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
749
Previous 709
5.64%
Holding current value
$13,189
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$214 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$206 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$196 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$52.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$41.8 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.85B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...